These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7323568)

  • 1. [Adenocarcinoma of the endometrium while undergoing contraceptive treatment with medroxyprogesterone].
    Stamm H; De Grandi P
    Rev Med Suisse Romande; 1981 Nov; 101(11):913-7. PubMed ID: 7323568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Apparent cure with a progestagen of endometrial cancer with pulmonary metastases].
    Legrand M; Eukirch
    Nouv Presse Med; 1976 Oct; 5(32):2086. PubMed ID: 980740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menometrorrhagia in an oral contraceptive user.
    Murphy NJ; Wallace DL; Behrend AE
    J Fam Pract; 1993 Feb; 36(2):229-31. PubMed ID: 8426144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Post-menopausal metrorrhagia: endometrial ultrasonic aspects].
    Longo M; Buzzi M; Abbondante G; Giovagnorio P; Vitagliano M; Tocci B; Eleuteri Serpieri D; Napolitano C
    G Ital Oncol; 1990; 10(1-2):19-22. PubMed ID: 2192983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate.
    Mitsushita J; Toki T; Kato K; Fujii S; Konishi I
    Gynecol Oncol; 2000 Oct; 79(1):129-32. PubMed ID: 11006045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced adenocarcinoma of the endometrium with melphalan, 5-fluorouracil, and medroxyprogesterone acetate: a preliminary study.
    Cohen CJ; Deppe G; Bruckner HW
    Obstet Gynecol; 1977 Oct; 50(4):415-7. PubMed ID: 904803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal cytologic evaluation as a practical link between hormone blood levels and tumor hormone dependency in exclusive medroxyprogesterone treatment of recurrent or metastatic endometrial adenocarcinoma.
    Bonte J; Decoster JM; Ide P
    Acta Cytol; 1977; 21(2):218-24. PubMed ID: 266331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Flow cytometric study on the action of progestogen in patients with adenocarcinoma and precancerous lesions of the endometrium].
    Nishiya I; Izutsu T; Satoh K; Yoshizumi N; Kurokawa Y; Kagabu T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1161-8. PubMed ID: 3161958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medroxyprogesterone and endometrial adenocarcinoma].
    Serment H; Spitalier JM; Ayme Y; Degiovanni E; Bardin JP
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(1):93-7. PubMed ID: 5453572
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial hyperplasia. Clinico-pathological considerations of a prospective randomised study after abrasio only or high-dose gestagen treatment. Results of 2 years follow-up of 292 patients.
    Lindahl B; Willén R
    Anticancer Res; 1991; 11(1):403-6. PubMed ID: 1826823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
    Kaunitz AM
    J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turner's syndrome with endometrial adenocarcinoma and stilbestrol therapy.
    Wilkinson EJ; Friedrich EG; Mattingly RF; Regali JA; Garancis JC
    Obstet Gynecol; 1973 Aug; 42(2):193-200. PubMed ID: 4721406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progestins in the treatment of endometrial carcinoma.
    Anderson DG
    Surg Forum; 1965; 16():398-400. PubMed ID: 5835208
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of highly atypical hyperplasia--difficult to differentiate from carcinoma].
    Katayama S; Furukawa T; Omura G; Kubo H; Momose K; Kameda N
    Gan No Rinsho; 1984 Jun; 30(7):865-70. PubMed ID: 6748252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic or recurrent endometrial carcinoma. Preliminary report.
    Piver MS; Lele S; Barlow JJ
    Obstet Gynecol; 1980 Sep; 56(3):370-2. PubMed ID: 7422177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with progestational agents in the advanced phase of carcinoma of the endometrium. Study of 137 patients treated at the 1st division of obstetrics and gynecology of the San Camillo De Lellis Hospital in Rome].
    Rendina GM; Donadio C
    Minerva Ginecol; 1975 Dec; 27(12):1026-30. PubMed ID: 778677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between adenocarcinoma in both endocervical and endometrial specimens from fractional curettage and pathologic findings in subsequent hysterectomy specimens.
    Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S
    J Med Assoc Thai; 2008 Sep; 91(9):1313-7. PubMed ID: 18843857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytologic evaluation of exclusive medroxyprogesterone acetate treatment for vaginal recurrence of endometrial adenocarcinoma.
    Bonte J; Drochmans A; Ide P
    Acta Cytol; 1970 May; 14(5):353-6. PubMed ID: 5284269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.